Dexlansoprazole
TAK-390MR(OD)_107
Approved small_molecule completed
Quick answer
Dexlansoprazole for Gastroesophageal Reflux Disease is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Gastroesophageal Reflux Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed